Recently, a report says that the global PCR technologies market is expected to grow from nearly $6.8 billion in 2013 to nearly $10.2 billion by 2018, an estimated compound annual growth rate (CAGR) of 8.5% from 2013 to 2018.
What drives the market for PCR? The reason lies in the increasing demand for technologies supporting early and accurate diagnosis of life-threatening diseases, such as cancer. Additionally, investment in research is increasing with respect to gene therapy. Despite the economic recession, these investments are further driving the growth of the PCR market. PCR is increasingly being applied in key research that is expected to solve numerous medical mysteries and breakthrough technologies supporting drug discovery.
Hence, we can conclude that PCR will be applied in many more areas and used by more researchers. It is absolutely that PCR have a more much bright future.
PCR technology has undergone decades of development. With the development of real-time PCR, PCR technology has made a big step forward. Real-time quantitative PCR detection is the most sensitive and most reliable method of gene expression. By the test, PCR achieves real-time monitoring of the fluorescent dye signal to reflect the number changes of copies of the gene in the sample. However, due to the need for standard curve preparation and the simultaneous analysis of reference genes, PCR can only detect the expression levels of a few genes for each experiment. The detection of a large number of genes is still a huge work which is very time-consuming.
Here goes the answer, Creative Biogene provides Real-Time-PCR to amplify and simultaneously quantify a targeted DNA molecule for researchers. Researchers can proceed with their researches without adding any new staffs and time. All you shall do is just contacting Creative Biogene and we will do it for you as you required.
Tags: PCR, Polymerase Chain Reaction